Note to Industry on Requirement for Bioequivalence Study
Bioequivalence (BE) study is a clinical trial designed to demonstrate that two pharmaceutical products, typically a generic drug and its corresponding reference innovator brand have similar bioavailability and efficacy hence, interchangeable healthcare practices. Over 90% of drug products used in the country are generics with which access and affordability is created without compromising quality. Presently, […]
